Murray Statement on FDA Advisory Committee's Unanimous Vote to Recommend Approval of OTC Birth Control

Statement

Date: May 10, 2023
Location: Washington, D.C.

"This is an enormous step forward in the fight to expand access to contraception in America--a fight that is even more important today in a world without Roe. Now, FDA should trust the experts--who voted unanimously in support of this application--and must not delay in getting over-the-counter birth control on the shelves for American women.

Women use over-the-counter birth control in more than 100 countries--and it's long past time American women had that option as well. In the face of so many other barriers women face to controlling their reproductive lives and futures, we need to be doing everything we possibly can to make it easier to access and afford birth control. Today's vote takes us one step closer to getting there."


Source
arrow_upward